A new platform called Model Gateway has been developed to manage machine learning and scientific computational models specifically for drug discovery. This cloud-based system offers features like version control, governance structured around scientific units, asynchronous execution, and a unified API for various clients, including LLM agents. Currently in production at Eli Lilly and Company, Model Gateway oversees over 200 deployed models across different therapeutic modalities and supports multiple downstream applications in the drug discovery process. AI
IMPACT This platform could accelerate the integration of AI models into pharmaceutical research pipelines.
RANK_REASON The item describes a research paper detailing a new platform for drug discovery, not a commercial product release or a frontier model. [lever_c_demoted from research: ic=1 ai=0.7]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
